Analyst Ratings for CVS Health Corp. (CVS)

Updated: 2017-07-28

Analysts covering CVS Health Corp. (NYSE:CVS) have given it a consensus rating of Overweight. CVS had previously received a consensus rating of Overweight a month ago.

A buy rating was issued by 16 analysts, 1 gave an overweight rating, 8 issued a hold rating, 0 issued an underweight rating, and 0 issued a sell rating. Compared to three months ago, there has been an decrease of 1 in the number of analysts with a positive outlook on the stock. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.

CVS was given price targets by several analysts. The most optimistic analyst gave a price target of 109, which equates to a potential upside of 38.11 percent. The most pessimistic analyst gave a price target of 77, which equates to a potential downside of -2.43 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

Analysts have revised their earnings estimates upwards for this quarter, by about 0 percent on average, compared to last month. This can be compared with the average change in earnings estimates over the past 3 months, which is -0.76 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 0.17 percent.

Another thing investors often look at is the level of agreement among analysts' revisions. Over the past month, 0 analysts increased their quarterly estimates, while 0 analysts made negative revisions. Over the same time period, 3 analysts revised their FY earnings estimates upwards, compared to 0 analysts that revised their FY estimates downwards.

Analysts estimate earnings of CVS to grow at a rate of 23.24 percent. Another measure frequently examined by investors is the PEG ratio. A lower PEG ratio is favorable, because people typically see that as an indicator of higher growth relative to stock price. Wall Street investors typically prefer a PEG ratio to be smaller than 1, though it could be better to see where the ratio stands relative to peers in the industry. The PEG ratio of CVS is 0.71.

CVS has traded between a high of 98.66 and a low of 69.30 over the past year. The current market price is above the trailing year's low by 13.88 percent, and below the high by 20.01 percent. CVS has a price/earnings ratio of 16.44. Investors typically compare the P/E ratio to a company's peers in the industry. The CVS value stock report compares CVS to some of its peers using value stock charts. The market cap of CVS is $79.76 billion. CVS's next earnings release will be on 0000-00-00, which is days away.